Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Submitted by
admin
on March 23, 2018 - 9:45am
Source:
Drug Delivery Business News
News Tags:
Japan
Novo Nordisk
diabetes
type 2 diabetes
Ozempic
Headline:
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Do Not Allow Advertisers to Use My Personal information
